Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Aline Silva de Miranda, Fabrício A. Moreira & Antônio Lúcio Teixeira. (2017) The preclinical discovery and development of quetiapine for the treatment of mania and depression. Expert Opinion on Drug Discovery 12:5, pages 525-535.
Read now
Read now
Svetlana A. Ivanova, Diana Z. Osmanova, Maxim B. Freidin, Olga Yu Fedorenko, Anastasia S. Boiko, Ivan V. Pozhidaev, Arkadiy V. Semke, Nikolay A. Bokhan, Alexey A. Agarkov, Bob Wilffert & Anton J.M. Loonen. (2017) Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia. The World Journal of Biological Psychiatry 18:3, pages 239-246.
Read now
Read now
Chi-Un Pae, Soo-Jung Lee, Changsu Han, Ashwin A Patkar & Prakash S Masand. (2013) Atypical antipsychotics as a possible treatment option for irritable bowel syndrome. Expert Opinion on Investigational Drugs 22:5, pages 565-572.
Read now
Read now
Yan Li, Huafang Li, Yan Liu, Xiaolei Yan, Ying Yue & Mincai Qian. (2012) Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study. Current Medical Research and Opinion 28:10, pages 1725-1732.
Read now
Read now
Susan L McElroy, Anna Guerdjikova, Nicole Mori & Paul E Keck Jr. (2010) Therapeutic potential of new second generation antipsychotics for major depressive disorder. Expert Opinion on Investigational Drugs 19:12, pages 1527-1544.
Read now
Read now
Arun V Ravindran, Abdullah Al-Subaie & Gebrehiwot Abraham. (2010) Quetiapine: novel uses in the treatment of depressive and anxiety disorders. Expert Opinion on Investigational Drugs 19:10, pages 1187-1204.
Read now
Read now
Roger S McIntyre, David J Muzina, Amanda Adams, Maria Teresa C Lourenco, Candy WY Law, Joanna K Soczynska, Hanna O Woldeyohannes, Jay Nathanson & Sidney H Kennedy. (2009) Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials. Expert Opinion on Pharmacotherapy 10:18, pages 3061-3075.
Read now
Read now
Inmaculada Tasset, José Peña, Ignacio Jimena, Montserrat Feijóo, María del Carmen Muñoz, Pedro Montilla & Isaac Túnez. (2008) Effect of 17β-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats. Neuropsychiatric Disease and Treatment 4:2, pages 441-449.
Read now
Read now
Articles from other publishers (41)
Anton S. Tsybko, Elena M. Kondaurova, Elena A. Zalivina, Varvara O. Blaginya & Vladimir S. Naumenko. (2023) Effects of Chronic Combined Treatment with Ketanserin and Fluoxetine in B6.CBA-D13Mit76C Recombinant Mice with Abnormal 5-HT1A Receptor Functional Activity. Biochemistry (Moscow) 88:6, pages 758-769.
Crossref
Crossref
Tatiana Ilchibaeva, Anton Tsybko, Andre Zeug, Franziska E. Müller, Daria Guseva, Stephan Bischoff, Evgeni Ponimaskin & Vladimir Naumenko. (2022) Serotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes. Cells 11:15, pages 2384.
Crossref
Crossref
Xiaorui Wang, Yixun Su, Tao Li, Guangdan Yu, Yuxin Wang, Xiaoying Chen, Chenrui Yin, Ziqin Tang, Chenju Yi, Lan Xiao & Jianqin Niu. (2021) Quetiapine promotes oligodendroglial process outgrowth and membrane expansion by orchestrating the effects of Olig1. Glia 69:7, pages 1709-1722.
Crossref
Crossref
Risa Fukushi, Yuki Nomura, Masataka Katashima, Kanji Komatsu, Yuichiro Sato & Akitsugu Takada. (2020) Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression. Clinical Therapeutics 42:6, pages 1067-1076.e2.
Crossref
Crossref
Thomas RE Barnes, Richard Drake, Carol Paton, Stephen J Cooper, Bill Deakin, I Nicol Ferrier, Catherine J Gregory, Peter M Haddad, Oliver D Howes, Ian Jones, Eileen M Joyce, Shôn Lewis, Anne Lingford-Hughes, James H MacCabe, David Cunningham Owens, Maxine X Patel, Julia MA Sinclair, James M Stone, Peter S Talbot, Rachel Upthegrove, Angelika Wieck & Alison R Yung. (2019) Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 34:1, pages 3-78.
Crossref
Crossref
Sudhir Chandra Sarangi, Nivendeep Kaur & Manjari Tripathi. (2019) Assessment of psychiatric and behavioral adverse effects of antiepileptic drugs monotherapy: Could they have a neuroendocrine correlation in persons with epilepsy?. Epilepsy & Behavior 100, pages 106439.
Crossref
Crossref
Zuleide Maria Ignácio, Ana Valquíria Calixto, Ritele Hernandez da Silva, João Quevedo & Gislaine Zilli Réus. (2018) The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies. Neuroscience & Biobehavioral Reviews 86, pages 36-50.
Crossref
Crossref
Henk S Temmingh, Taryn Williams, Nandi Siegfried & Dan J Stein. (2018) Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. Cochrane Database of Systematic Reviews 2018:2.
Crossref
Crossref
Zuleide M. Ignácio, Gislaine Z. Réus, Helena M. Abelaira, Airam B. de Moura, Thays G. de Souza, Danyela Matos, Mariana P. Goldim, Khiany Mathias, Leandro Garbossa, Fabricia Petronilho & João Quevedo. (2017) Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain. Metabolic Brain Disease 32:4, pages 1195-1208.
Crossref
Crossref
Dong-Wook Kim, Kwon-Yeon Weon, Eon-Pyo HongEun Kyoung Chung & Kyung-Tae Lee. (2016) Comparative Physicochemical and Pharmacokinetic Properties of Quetiapine and Its Active Metabolite Norquetiapine. CHEMICAL & PHARMACEUTICAL BULLETIN Chemical and Pharmaceutical Bulletin 64:11, pages 1546-1554.
Crossref
Crossref
Jimmi Nielsen, Jørgen Matz, Aurelia Mittoux, Christoffer Polcwiartek, Johannes J. Struijk, Egon Toft, Jørgen K. Kanters & Claus Graff. (2015) Cardiac effects of sertindole and quetiapine: Analysis of ECGs from a randomized double-blind study in patients with schizophrenia. European Neuropsychopharmacology 25:3, pages 303-311.
Crossref
Crossref
Rita Citraro, Antonio Leo, Rossana Aiello, Michela Pugliese, Emilio Russo & Giovambattista De Sarro. (2014) Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats. Neurotherapeutics 12:1, pages 250-262.
Crossref
Crossref
Angela E. McLelland, Mathew T. Martin-Iverson & Richard J. Beninger. (2014) The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine. Psychopharmacology 231:22, pages 4349-4359.
Crossref
Crossref
Rebecca Waite. (2014) Use of second generation antipsychotics for treatment-resistant major depressive disorder. Mental Health Clinician 4:5, pages 246-256.
Crossref
Crossref
Mark J. Millan. (2013) On ‘polypharmacy’ and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal. The International Journal of Neuropsychopharmacology 17:07, pages 1009-1037.
Crossref
Crossref
Stefano Porcelli, Beatrice Balzarro, Diana de Ronchi & Alessandro Serretti. (2014) Quetiapine Extended Release. Journal of Clinical Psychopharmacology 34:3, pages 303-306.
Crossref
Crossref
Elena P. Calandre, Fernando Rico-Villademoros, Jaime Galán, Rocio Molina-Barea, Juan S. Vilchez, Carmen M. Rodriguez-Lopez, Javier Hidalgo-Tallon & Piedad Morillas-Arques. (2014) Quetiapine extended-release (Seroquel-XR) versus amitriptyline monotherapy for treating patients with fibromyalgia: a 16-week, randomized, flexible-dose, open-label trial. Psychopharmacology 231:12, pages 2525-2531.
Crossref
Crossref
Jeremy D. Coplan, Srinath Gopinath, Chadi G. Abdallah & Benjamin R. Berry. (2014) A Neurobiological Hypothesis of Treatment-Resistant Depression – Mechanisms for Selective Serotonin Reuptake Inhibitor Non-Efficacy. Frontiers in Behavioral Neuroscience 8.
Crossref
Crossref
Henk S Temmingh, Taryn Amos, Nandi Siegfried & Dan J Stein. (2014) Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Giuseppe Peddio, Barbara Pittau, Ilaria Manca, Roberta Salis, Luca Pani & Luigi Pira. (2013) Validated Method to Determine Quetiapine and Norquetiapine in Microsomal Matrix by LC MS–MS: Implication in Quetiapine Metabolism. Chromatographia 77:1-2, pages 75-82.
Crossref
Crossref
Julia Diemer, Katharina Domschke, Andreas Mühlberger, Bernward Winter, Maxim Zavorotnyy, Swantje Notzon, Karen Silling, Volker Arolt & Peter Zwanzger. (2013) Acute anxiolytic effects of quetiapine during virtual reality exposure—A double-blind placebo-controlled trial in patients with specific phobia. European Neuropsychopharmacology 23:11, pages 1551-1560.
Crossref
Crossref
M A Kondo, K Tajinda, C Colantuoni, H Hiyama, S Seshadri, B Huang, S Pou, K Furukori, C Hookway, H Jaaro-Peled, S-i Kano, N Matsuoka, K Harada, K Ni, J Pevsner & A Sawa. (2013) Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control. Translational Psychiatry 3:4, pages e243-e243.
Crossref
Crossref
Nandkishor R. Kotagale, Sachin M. Mendhi, Manish M. Aglawe, Milind J. Umekar & Brijesh G. Taksande. (2013) Evidences for the involvement of sigma receptors in antidepressant like effect of quetiapine in mice. European Journal of Pharmacology 702:1-3, pages 180-186.
Crossref
Crossref
Iria Grande, Flávio Kapczinski, Laura Stertz, Gabriela Delevatti Colpo, Mauricio Kunz, Keila Mendes Cereser, Marcia Kauer-Sant'Anna, Benicio Frey, Eduard Vieta & Pedro V.S. Magalhaes. (2012) Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder. Journal of Psychiatric Research 46:11, pages 1511-1514.
Crossref
Crossref
Diogo R. Lara, Luisa W. Bisol, Miriam G. Brunstein, Caroline T. Reppold, Hudson W. de Carvalho & Gustavo L. Ottoni. (2012) The Affective and Emotional Composite Temperament (AFECT) model and scale: A system-based integrative approach. Journal of Affective Disorders 140:1, pages 14-37.
Crossref
Crossref
Mark Sanford & Gillian M. Keating. (2012) Quetiapine. CNS Drugs 26:5, pages 435-460.
Crossref
Crossref
Konstantinos N. Fountoulakis, John R. Kelsoe & Hagop Akiskal. (2012) Receptor targets for antidepressant therapy in bipolar disorder: An overview. Journal of Affective Disorders 138:3, pages 222-238.
Crossref
Crossref
Mohammed Shahid. 2012. Designing Multi-Target Drugs. Designing Multi-Target Drugs
14
31
.
Monica M. Marcus, Kent Jardemark, Anna Malmerfelt, Jens Gertow, Åsa Konradsson-Geuken & Torgny H. Svensson. (2012) Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: Behavioral, biochemical, and electrophysiological evidence. Synapse 66:4, pages 277-290.
Crossref
Crossref
A. Carlo Altamura, Donatella Moliterno, Silvia Paletta, Massimiliano Buoli, Bernardo DellʼOsso, Massimo C. Mauri & Silvio R. Bareggi. (2012) Effect of Quetiapine and Norquetiapine on Anxiety and Depression in Major Psychoses Using a Pharmacokinetic Approach. Clinical Drug Investigation 32:3, pages 213-219.
Crossref
Crossref
Eirik Kjelby, Hugo A Jørgensen, Rune A Kroken, Else-Marie Løberg & Erik Johnsen. (2011) Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial. BMC Psychiatry 11:1.
Crossref
Crossref
Mark Sanford. (2011) Quetiapine Extended Release. CNS Drugs 25:9, pages 803-813.
Crossref
Crossref
Francisco E. Estevez-Carrizo, Susana Parrillo, Mónica Cedres Ercoli & Francisco T. Estevez-Parrillo. (2011) Single-Dose Relative Bioavailability of a New Quetiapine Fumarate Extended-Release Formulation: A Postprandial, Randomized, Open-Label, Two-Period Crossover Study in Healthy Uruguayan Volunteers. Clinical Therapeutics 33:6, pages 738-745.
Crossref
Crossref
Yu-Ren Chen, Ya-Ping Huang, Shan-Ju Lin, Tsao-Hsiang Kuan & Chin-Hsien Lin. (2010) Effectiveness of Quetiapine for Poststroke Pathological Laughing. Clinical Neuropharmacology 33:6, pages 319-322.
Crossref
Crossref
Carla Pisu, Luigi Pira & Luca Pani. (2010) Quetiapine anxiolytic-like effect in the Vogel conflict test is serotonin dependent. Behavioural Pharmacology 21:7, pages 649-653.
Crossref
Crossref
Simon Zhornitsky, Stéphane Potvin, Emmanuel Stip & Pierre-Paul Rompré. (2010) Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine. European Neuropsychopharmacology 20:10, pages 695-703.
Crossref
Crossref
Chi-Un Pae. (2010) Effect of quetiapine-XR on irritable bowel syndrome. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:6, pages 1162-1163.
Crossref
Crossref
Luísa W Bisol & Diogo R Lara. (2008) Low-dose quetiapine for patients with dysregulation of hyperthymic and cyclothymic temperaments. Journal of Psychopharmacology 24:3, pages 421-424.
Crossref
Crossref
Christer Allgulander. (2009) Generalized Anxiety Disorder: Between Now and DSM-V. Psychiatric Clinics of North America 32:3, pages 611-628.
Crossref
Crossref
Gry Vibeke Bakken, Ida Rudberg, Hege Christensen, Espen Molden, Helge Refsum & Monica Hermann. (2009)
Metabolism of Quetiapine by CYP3A4 and CYP3A5 in Presence or Absence of Cytochrome B
5
. Drug Metabolism and Disposition 37:2, pages 254-258.
Crossref
Crossref
Yves Chaput, Annick Magnan & Alain Gendron. (2008) The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: A preliminary trial. BMC Psychiatry 8:1.
Crossref
Crossref